MAPS Public Benefit Corporation (“MAPS PBC”), a company dedicated to transforming mental healthcare, announced an oversubscribed Series A financing....
Sexual abuse during psychedelic treatments continues to be a major issue within the industry. Sexual misconduct does happen during psychedelic treatments,...
–Recently announced positive Phase 2 topline data in Major Depressive Disorder (“MDD”) with 79% of patients in remission from depression after two...
If you’re interested in becoming a psychedelic therapist, deciding on how to train as one can be a bit of a minefield. There are now many...
The study also found a "statistically significant reduction" in suicidal ideation from participants. The post New Ibogaine Study for Vets Finds Positive...
“Neuroplasticity and Psychedelics” is a live webinar event brought to you by Wondermed and Neuly. It will be held on Monday, January 15th at 3pm ET....
Explore the future of mental wellness with our guide on psychedelic training, coaching, and certification, diving into the science and practices reshaping...
The company is a going concern, with a cumulative deficit of $4,132,349 as of August 31. The post PharmAla Biotech Reports Progress in Earnings appeared...
PharmAla Biotech Holdings Inc. (CSE: MDMA) (OTC: PMBHF)released its audited financial statements in Canadian dollars for the year ended on August 31, 2023....
Explore the Stamets Stack: a microdosing protocol combining psilocybin, Lion's Mane, and Niacin, for cognitive enhancement and mental wellness.